
---
title: '收评：创业板指跌2.17% 新冠药概念大幅反弹'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=6573'
author: 证券时报网
comments: false
date: Wed, 19 Jan 2022 15:02:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=6573'
---

<div>   
<p>证券时报e公司讯，1月19日，两市股指走弱，创业板表现较弱，盘中一度跌约3%。截至收盘，沪指跌0.33%，深证成指跌1.28%，创业板指跌2.17%。板块方面，新冠药概念大幅反弹，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SS688062" style="color: #2f67d1;text-decoration: none;" code="688062" target="_blank">迈威生物</a>涨30%，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SZ002349" style="color: #2f67d1;text-decoration: none;" code="002349" target="_blank">精华制药</a>等多只个股涨停。云游戏、数据中心、旅游、传媒娱乐等涨幅居前，锂矿、培育钻石、酿酒等跌幅居前。两市个股涨跌拉近各半，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SZ000661" style="color: #2f67d1;text-decoration: none;" code="000661" target="_blank">长春高新</a>等逾10只个股跌停。</p>

                  
</div>
            